Literature DB >> 4272484

Application of cost-benefit analysis to a PKU screening program.

K C Steiner, H A Smith.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4272484

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


× No keyword cloud information.
  6 in total

1.  The reliability of cost-utility estimates in cost-per-QALY league tables .

Authors:  S Petrou; M Malek; P G Davey
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Authors:  J Lord; M J Thomason; P Littlejohns; R A Chalmers; M D Bain; G M Addison; A H Wilcox; C A Seymour
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

3.  Assessing the cost-effectiveness of prevention.

Authors:  H D Banta; B R Luce
Journal:  J Community Health       Date:  1983

4.  A survey to evaluate parental consent as public policy for neonatal screening.

Authors:  R Faden; A J Chwalow; N A Holtzman; S D Horn
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

5.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11

6.  Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness.

Authors:  Huey-Fen Chen; Angela M Rose; Susan Waisbren; Ayesha Ahmad; Lisa A Prosser
Journal:  Children (Basel)       Date:  2021-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.